News
MedPage Today on MSN8h
'Immediately Practice-Changing' Trial in Small Cell Lung CancerCHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback